

Scores at time of recommendation (August 3, 2026)
2026-09-23 — Current market price
DCC (DCC.LSE) trades at 6430p as of this date, serving as the valuation reference point for the period.
2026 (year ended 31 March 2026) — Full-year results and dividend increase
DCC reported adjusted operating profit of £634.0m and adjusted EPS of 438.12p for the year ended 31 March 2026. The board proposed a total dividend of 216.72p per share, a 5.0% increase comprising an interim dividend of 69.50p and a final dividend of 147.22p payable on 23 July 2026. This marked the 32nd consecutive year of dividend growth, with dividend cover standing at 2.0x from adjusted EPS of continuing operations.
The results narrative emphasized DCC's resilience amid macro volatility and structural change. Management described the year as strong financial performance in the company's 50th year, positioning DCC as a steady compounder with reliable dividend growth and disciplined capital returns.
2026 (mid-year) — Healthcare division disposal
DCC agreed to sell its Healthcare division to an Investindustrial Advisors investment vehicle for an enterprise value of £1.05bn. The company signaled that proceeds would support shareholder returns including buybacks and special distributions.
Investors viewed this as portfolio reshaping—crystallizing value from a non-core asset and returning capital while allowing management to concentrate on higher-return businesses. The transaction was perceived as supportive of near-term shareholder distributions and long-term ROCE improvement.
2025 (year ended 31 March 2025) — Dividend growth and steady results
DCC announced FY2025 results with a 5.0% increase in the annual dividend, continuing its multi-decade record of consecutive annual increases. Performance across divisions remained resilient.
The results reinforced investor perception of DCC as a cash-generative, dividend compounder with defensive characteristics. Management messaging focused on disciplined capital allocation, balancing dividends and buyback capacity as the core value proposition in cyclical end-markets.
2024 — Portfolio management and targeted M&A
DCC continued acquisitions and disposals across energy, technology and healthcare segments as part of its buy-and-build strategy. Management reiterated focus on bolt-on acquisitions in higher-return segments.
Market sentiment split between income-focused shareholders valuing the dividend and value investors tracking ROCE improvements from the reshaping of the portfolio. DCC was viewed as executing a disciplined roll-up model across its three divisions.
2023 — Strong operating performance and EPS growth
DCC reported growth in adjusted operating profit and EPS (mid-hundreds pence per share) while continuing its dividend growth record.
Investor perception reinforced the compounder narrative. DCC was characterized as delivering consistent EPS and dividend growth through its decentralised divisional model, combining acquisition-driven growth with defensive cash flows.
2022 — Post-COVID recovery and margin resilience
DCC's divisional performance recovered from pandemic-related disruptions. Company communications highlighted margin resilience and continued acquisition activity supporting earnings.
Investor sentiment shifted from caution to confidence in the company's ability to re-accelerate M&A-driven growth and restore pre-pandemic profit trends. The stock increasingly was characterized as a resilient distributor with reliable cash generation.
2021 — Pandemic-era headwinds and strategic diversification
During 2020–2021 DCC navigated COVID-related headwinds across end markets. Management emphasized diversification across energy, healthcare and technology services while preserving dividend growth.
Market perception in 2021 remained cautious but respectful of DCC's diversified distribution model and management's capital allocation discipline. DCC was positioned as a defensive dividend compounder with acquisitive growth optionality as demand recovered.
DCC isn't a company you love—it's one you need. The group distributes energy, fuels, and IT infrastructure in markets where customers simply have no alternative to keeping operations running. That creates a stable, if growth-constrained, revenue base. The ongoing strategic repositioning—disposal of the healthcare business, focus on energy—generates near-term valuation impulses through potential portfolio transactions and capital returns. At the same time, Form 8.3 filings from recent days signal that institutional players like Millennium International are actively building exposure, which under Irish Takeover Rules and an open takeover process carries real weight. The improvement in EBIT margins to 3.5 percent shows efficiency measures are working, though net margins remain uncomfortably thin at under 0.1 percent. For investors who value stability and dividends over growth narratives, DCC is a solid, if unremarkable, proposition.
DCC plc (DCC.LSE) operates as a diversified international distributor across three main segments. Its energy division handles fuel, LPG, and HVO/biofuels distribution. The technology division covers IT and professional audiovisual distribution. Healthcare distribution rounds out the portfolio. The competitive landscape fragments by division. Energy faces pressure from regional and global distributors alongside major oil companies. Technology and healthcare divisions compete against both broadline and specialist distributors. Material risks span several dimensions. Commodity price exposure creates earnings volatility. Regulatory tightening and decarbonisation requirements pressure margins and business models. Execution risk accompanies the company's M&A activity and integration demands. Working capital intensity inherent to distribution creates credit strain potential, particularly in economic stress.
DCC plc operates as a diversified international distributor and services group spanning Energy, Technology through its Exertis division, and Environmental Services, with Healthcare operations largely wound down through recent disposals. Competition varies sharply by segment: Energy faces pressure from large integrated oil majors and regional fuel distributors, Exertis competes against broadline and specialist technology distributors, while Environmental Services encounters specialist waste and recycling operators. The company carries meaningful exposure to energy commodity price volatility and margin compression from larger integrated competitors, alongside execution and integration risk inherent in its acquisition-heavy model. Regulatory headwinds and decarbonization-driven demand shifts in fuel markets present structural challenges, as do foreign-exchange movements and macroeconomic softness across its geographically dispersed operations.
| Company | Ticker |
|---|---|
| Vivo Energy plc | VVO.LSE |
| SHV Holdings (SHV Energy operations) - Rubis group competitor | RUI.PA |
| Bunzl plc | BNZL.LSE |
| Ferguson plc | FERG.LSE |
| TD SYNNEX Corporation | SNX.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | DCC plc | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +0.70% | +4.34% | +0.42% |
| 3M | +3.29% | +0.30% | -2.78% |
| 6M | +42.81% | +30.20% | +20.14% |
| 1Y | +41.24% | +34.21% | +23.43% |
| 3Y | +58.69% | -8.28% | -29.04% |
| 5Y | +23.09% | -40.06% | -63.23% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 471.9 | 0.4 | 2.8 | 9.2 |
| 1Y ago | 10.6 | 0.1 | 1.5 | 8.0 |
| 3Y ago | 9.0 | 0.1 | 1.5 | 8.2 |
| 5Y ago | 14.0 | 0.3 | 2.3 | 5.9 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 1.47 GBP | 2.43% | 1.64% |
| 2025 | 0.70 GBP | 1.41% | |
| 2025 | 1.40 GBP | 2.94% | |
| 2024 | 0.66 GBP | 1.18% | |
| 2024 | 1.34 GBP | 2.33% | |
| 2023 | 0.63 GBP | 1.18% | |
| 2023 | 1.27 GBP | 2.61% | |
| 2022 | 0.60 GBP | 1.35% | |
| 2022 | 1.20 GBP | 2.10% | |
| 2021 | 0.56 GBP | 0.93% | |
| 2021 | 1.08 GBP | 1.74% | |
| 2020 | 0.52 GBP | 0.93% | |
| 2020 | 0.96 GBP | 1.41% | |
| 2019 | 0.49 GBP | 0.76% | |
| 2019 | 0.93 GBP | 1.32% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | 15.44B | 18.01B | 19.86B | 22.20B | 17.73B |
| Operating income (EBIT) | 532.94M | 396.34M | 529.40M | 511.99M | 458.36M |
| Net income | 13.36M | 206.49M | 326.25M | 334.02M | 312.37M |
| Free cash flow | 475.45M | 367.73M | 491.67M | 427.46M | 257.42M |
| Total assets | 8.27B | 9.26B | 9.48B | 9.84B | 9.56B |
| Equity | 2.26B | 3.07B | 3.09B | 2.98B | 2.91B |
| Net debt | 1.19B | 1.19B | 1.20B | 1.18B | 943.58M |